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Introduction
RNA, has recently emerged as an important nanotechnology 
platform due to its extraordinary diversity in structure and function 
[1,2]. Small interfering RNA (siRNA), showed significant potential in 
new molecular approaches to down-regulate specific gene expression 
in mammalian cells [3]. In fact, targeted gene suppression by antisense 
DNA and siRNA has shown promising preclinical results, and/or is 
currently in clinical trials for a variety of diseases, including many 
forms of cancer (e.g., melanoma, neuroblastoma, and pancreatic 
adenocarcinoma), genetic disorders, and macular generation [4-6]. 
Despite the high therapeutic potential of siRNA, its application for 
clinical medicine is still limited mainly due to the lack of appropriate 
delivery systems. In such a situation, the development of clinically 
suitable, safe, and effective drug-delivery biomaterials [7] are required 
for the widespread use of siRNA therapeutics for disease treatment. 
A variety of materials have been explored for delivering siRNAs 
including liposomal delivery [8,9], nanoparticles made of synthetic 
cationic polymers [10], polymeric protein spheres [11,12] and etc. 
However, conventional delivery materials such as lyposomes and 
polymeric systems are heterogeneous in size, composition and surface 
chemistry, and this can lead to suboptimal performance and potential 
toxicity. Therefore sonochemistry [13] offers an alternative synthetic 
pathway for conversion of RNA molecules, without chemical structure 
modification, into a dense RNA nanoparticles. The sonochemically-
induced assembly of nanoparticles [14-16] from siRNA involves 
cooperative interaction of individual RNA molecules that assemble 
in a predefined manner to form a larger three-dimensional structure, 
which size and composition are precisely controlled. Moreover, the 
sonochemical siRNA nanoparticulation stabilize siRNA molecules. 
In this manner silencing activity of siRNA nanoparticles achieved 
through its dissociation to individual RNA molecules inside the cells. 
Nanoparticulate RNAs produced by this method have been shown to 
be resistant to a variety of environmental stresses including a wide 
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Abstract
The knowledge that small RNAs can affect gene expression has had a tremendous impact on basic and applied 
research, and gene silencing is currently one of the most promising new approaches for disease therapy. However, 
RNAs cannot easily penetrate cell membranes, therefore RNA delivery become one of the major challenges for gene 
silencing technology. In the current paper we discuss a general approach for converting siRNA molecules into a dense 
siRNA nanoparticles using environmentally friendly sonochemical method. The RNA nanoparticulation enhance its 
gene-silencing activity in vascular bovine endothelial as well as in cancer 293T/GFP-Puro cell lines without causing any 
toxic effect. We show that ultrasonic waves do not lead to RNA degradation or any changes in its chemical structure. 
Moreover, sonochemically produced siRNA nanoparticles have been shown to be resistant to a variety of environmental 
stresses including pH levels, enzymes and temperatures, hence solving problem of the short half-life of the RNA 
molecules. As the siRNA nanoparticles are biocompatibile and biodegradabile, and their RNA release properties may 
be controlled within limits, sonochemical formation of siRNA nanoparticles represent a new promising approach for 
generation of functional bionano materials.
range of pH levels, temperatures, and presence of RNases in the media. 
Being able to use nanoparticles with sizes of below 100 nm avoids the 
problem of the short half-life of small molecules in vitro [17] because 
of short retention time. Thus we probed the gene-silencing properties 
of nanoparticulate siRNA for endothelial bovine [18,19] and 293T/
GFP-Puro [20] cell cultures. Endothelial bovine aorta cells are thought 
to play important roles in controlling hemostasis and blood vessel 
permeability [21]. Correspondingly, altered structure and function 
of endothelial cells might contribute significantly to the pathogenesis 
of disorders or the arterial wall. Additionally, this is a not easy task to 
lead to penetration of siRNA to normal, not cancer cells. Two silencing 
activities were successfully achieved for anti-GFP siRNA [22] and 
luciferase RNA molecules [23]. The sonochemical method for siRNA 
nanoparticle synthesis represents a new and promising approach for the 
generation of a new class of functional nanomaterials for therapeutic 
applications.
Methods
Sonochemical synthesis of siRNA nanoparticles
Nanoparticles were created via ultrasonic emulsification method 
from the aqueous siRNA solution of following concentrations: 2 µM, 
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3 µM, 5 µM, 10 µM and 15 µM. Three types of siRNA molecules were 
converted into nanoparticles: 1) Cy3RNA of the following sequence 
3’-/5Cy3/rArGrCrArCrArArUrGrCrGrUrCrUrGrUrUrGrGrC/
iCy3/rCrCrArGrCrUrGrCrUrArCrUrGrGrGrArGrCrUrU, Syntezza 
Bioscience, IDT, Israel). RNA containing Cy3-fluorescent tag 
(excitation 550 nm, emission 570 nm, quantum yield 0.04) was used 
for particles tracking inside the cells; 2) siRNA (target sequence: 
5’-GCCATTCTATCCTCTAGAGGATGAAG-3’) for renilla-firefly 
lucefirase silencing (Thermo scientific) was used for firefly gene 
silencing activity studies; and 3) anti-Green Fluorescent Protein 
(GFP) (Target sequence:5’-GATCCCCGCAAGCTGACCCTGAAG
TTCTTCAAGAGAGAACTTCAGGGTCAGCTTGCTTTTTGGA
AA-3’), Accell eGFP Control siRNA (Thermo Scientific) for silencing 
GFP gene. The siRNA, maintained in storage buffer (5X storage 
buffer composition: 300 mM KCL, 30 mM HEPES pH 7.5 (with trace 
elemental impurities of Na≈0.05%, Cl≈0.05%, Ca≈0.01% and etc., 
see Thermo Scientific siRNA storage HEPES buffer trace elemental 
impurities), 1mM MgCl2) was redissolved in doubly distilled water 
(DDW). The bottom of a high-intensity ultrasonic horn (Sonic and 
Materials, VC-600, 20 kHz, 0.5 in a Ti horn, at 30% amplitude) was 
positioned at 1 cm from the water/air interface of the siRNA solution, 
followed by a sonication at an amplitude of 30% at 10°C (±1) for 1, 3, 
5, 10 and 15 minutes (employing an acoustic power of ≈58 W/cm2). 
After nanoparticle preparation was accomplished, unreacted free 
siRNA was removed using two separation methods: 1) precipitation 
of nanoparticles by centrifugation at 13000 rpm for 15 min or 2) by 
dialysis in PBS. siRNA was quantified by measuring its UV absorbance 
at 260 nm, using NanoDrop 2000 UV-Spectrophotometer. The free 
siRNA (not incorporated into the nanoparticles) was removed from the 
solution by dialyzing (using a dialysis tubing cellulose membrane with 
molecular weight cut-off of 14000 Da, Sigma-Aldrich) ain PBS for 24 h. 
The dialysis was conducted for 7 mL of sample in 250 mL of PBS, which 
was renovated twice. siRNA was then quantified spectroscopically, 
before and after dialysis, using a NanoDrop 2000 Spectrophotometer. 
The obtained results showed only <5% of siRNA that was estimated to 
be free and thus removed by dialysis. 
Efficiency studies for siRNA nanoparticles formation
The efficiency of the ultrasonic method in converting siRNA 
molecules into nanoparticles was calculated using UV-Vis spectroscopy 
(Carry100 spectrophotometer) for the absorbance values measured at 
260 nm. The absorption of the individual unreacted siRNA molecules 
(for both separation methods: centrifugation and dialysis) was measured 
by collecting the upper part of the aqueous solution after the separation 
of the nanoparticles by centrifugation at 13000 rpm for 15 min or by 
measuring free RNA in dialysis media (washing solution outside the 
dialysis bag). Subtracting the amount of the free RNA from the original 
amount of the RNA molecules we obtained the total amount of siRNA 
converted into nanoparticles. The calculated efficiency of siRNA 
nanoparticles formation separated by centrifugation and dialysis 
methods was found to be 91% and 95%, respectively. We assume 
that these small differences in the efficiency values come from the 
partial dissociation of siRNA nanoparticles during the centrifugation-
separation process. 
siRNA nanoparticles stability studies
The stability of the siRNA nanoparticles was studied by HRSEM 
microscopy. For the enzymatic stability studies of siRNA nanoparticles 
the RNase type-IIA (Ribonuclease A from bovine pancreas Type II-A, 
Sigma) was added to the particles dispersion following standard protocol 
(Sigma). Then the nanoparticles aqueous solution was analyzed using 
dynamic light scattering (following the disappearance of nanoparticles 
peak) and high resolution electron microscopy analysis. The siRNA 
nanoparticles were found to be stable in the presence of RNase II for 
3 hours. In order to measure the stability of siRNA nanoparticles at 
different temperatures (4°C, 25°C and 37°C), the temperature of 
nanoparticles solution was adjusted either by placing the reaction 
flask in refrigerator (4°C) or heating the solution up to 37°C. The 
nanoparticles dissociation was followed by above described methods. 
siRNA nanoparticles were found to be stable for 1 month at 4°C, for 24 
hours at 25°C and for 70 min at 37°C. The stability of nanoparticles in 
media with different pH values was checked adjusting pH by adding to 
nanoparticles solution concentrated HCl or NaOH. The nanoparticles 
dissociation was followed by above described methods. The siRNA 
nanoparticles were found to be stable for 24 hours at pH values ranging 
from 4.5 to 9.
The dissociation of siRNA nanoparticles as well as free siRNA 
molecules degradation under ultrasonic waves was followed by 
primer extension method. The products were separated on 6% 
polyacrylamide/7 M urea gels and visualized by autoradiography (See 
results in Supporting Information).
Introduction of siRNA nanoparticles into the cells and gene 
silencing activity assay
Vascular endothelial cells were prepared from segments of 
the descending bovine aorta obtained from a local slaughterhouse 
(Kibbutz Lahav, Israel). Bovine aortic endothelial cells were harvested 
by a modification of the method described elsewhere [24], washed 
with phosphate buffer solution (PBS), and scraped gently with a sterile 
stainless steel spatula. The scraped cells were plated on fibronectin-
coated tissue culture dishes in DMEM containing 10% FCS, 50 mg/
ml penicillin and 50 mg/ml streptomycin. Areas of pure endothelial 
cells were enclosed with cylinder rings, trypsinized, and replated on 
fibronectin-coated dishes. The cultures derived from several aortae were 
passages weekly (1:3 split ratio) and confluent, highly organized cultures 
between the 4th and the 18th passages were used for experiments. The 
cultures were maintained at 37°C in a humidified 5% CO2 incubator. 
The Cy3RNA nanoparticles suspension (3.8 uM) was added to the cells 
media and incubated for 1 h. The internalization of the nanoparticles 
inside the cells was visualized using confocal microscopy.
For gene silencing activity tests, the bovine cells were incubated 
in 96 well plate (4×103 cells/well) with lucefirase RNA nanoparticles 
created via 1 and 3 min sonication time (3.8 uM) and free siRNA, for 1 
h, then the media was replaced followed by additional incubation for 48 
hours. The gene silencing activity was monitored using Pierce Renilla-
Firefly Lucefirase dual assay kit protocol (Thermo scientific). The 
firefly gene repression was measured at 613 nm fluorescent emission 
wavelength. The GFP gene silencing activity was probed for 293T/GFP-
Puro cell line from Cell Biolabs that was routinely grown in T75 tissue 
culture flasks at 37°C, in a humidified 5% CO2 atmosphere. The cells 
were grown in Dulbecco´s Modified Eagle’s Medium containing 4.5 g/L 
glucose and 1.5 g/L sodium bicarbonate (Sigma), supplemented with 
2 mM L-glutamine, 10% of fetal bovine serum (FBS), 0.1 mM MEM 
Non-Essential Amino Acids (NEAA), 1% Streptomycin-Penicillin and 
2 µg/mL Puromycin. 293T/GFP cells were seeded in 24 well plates (TPP, 
Switzerland) at a density of 7.5×104 cells/well and incubated overnight 
to promote cell adhesion. Cells were exposed to solutions of anti-
GFP siRNA and to anti-GFP siRNA nanoparticles at a concentration 
of 1 µM and the gene silencing effect was monitored directly under 
a fluorescence microscopy (Olympus IX71). The quantification of 
percentage of GFP silencing was monitored by measuring fluorescence 
Citation: Shimanovich U, Munder A, Loureiro A, Azoia NG, Gomes A, et al. (2014) Gene Silencing by siRNA Nanoparticles Synthesized via 
Sonochemical Method. J Nanomed Nanotechnol 5: 204. doi:10.4172/2157-7439.1000204
Page 3 of 5
Volume 5 • Issue 3 • 1000204
J Nanomed Nanotechnol
ISSN: 2157-7439 JNMNT, an open access journal
Nanotechnology: Targeted Drug Delivery
intensities emitted from untreated and treated cells (emission 520 nm). 
These values were determined by treatment of images correspondent to 
different conditions. 
Cell viability assay
Endothelial bovine aorta cells were incubated in a 96 well plate with 
1 uM, 4 uM and 10 uM of siRNA nanoparticles for 1 h, washed and 
followed by additional incubation for 24 h at 37°C. After incubation 
was accomplished, the cell viability was measured using CellTiter 
96 Aqueous One Solution Cell Proliferation Assay (MTS, Promega) 
according to standard protocol.
Characterization methods
The morphology of the siRNA nanoparticles was examined by 
high resolution electron microscope (HRSEM, FEI, Magellan 400 L) 
and scanning transmission electron microscopy (STEM). For the 
HRSEM analysis the samples were prepared by depositing the aqueous 
dispersions, without further purification, on a glass-slide, drying and 
coating with a thin layer of carbon. For STSEM analysis the samples 
were deposited on copper grids with carbon film 400 meshes, 3 mm 
diameter, and analyzed in a NOVA Nano SEM 200 FEI. The microscope 
was operated at 10 kV and samples viewed at a working distance of 8 
mm and 10 000x magnification.
For fluorescent and confocal microscopy analysis the samples 
(bovine cells loaded with Cy3 RNA nanoparticles and 293T/GFP-Puro 
cell incubated with ant-GFP-siRNA nanoparticles) were analyzed by 
confocal microscopy (Laser Scan Confocal, Zeiss Microscope) using 
tunable Argon 514 nm laser at 30 mW (for yellow excitations), and 
fluorescent (Olympus IX71) microscope using GFP filter (488/520 nm). 
DLS measurements and zeta-potential measurements were carried 
out on an ALV/CGS-3 compact goniometer system equipped with 
an ALV/LSE-5003 light scattering electronic and multiple digital 
correlator, and a 632.8 nm JDSU laser 1145P. DLS and zeta-potential 
experiments were carried out on a siRNA nanoparticles solution. Each 
measurement took 10 s; the electrical charge distribution was obtained 
by averaging ten DLS measurements.
The Inductively Coupled Plasma analysis was performed for diluted 
(with DDW) siRNA nanoparticles solution (initial concentration 3.8 
uM) to 50 ml of total volume on atomic emission spectrometer. The 
following ions were detected in the RNA solution: Na+, Mg2+ and Ca2+. 
The quality of the sonochemically treated siRNA was assessed by a 
primer extension technique and compared to the untreated siRNA. The 
siRNA molecules converted into the nanoparticles were extracted using 
a phenol:chloroform extraction method and further precipitated with 
ethanol according to the manufacturer’s instructions. The products 
were visualized on polyacrylamide gel (See results in Supporting 
Information).
Results and Discussion
To explore the potential nano confinement to silence the genes, we 
formed siRNA nanoparticles by passing ultrasonic waves through the 
aqueous siRNA solution. The fraction of RNA converted to particles 
was measured by monitoring the concentration of free RNA by UV 
absorption, revealing that the conversion efficiency of over 90% (See 
Methods). We further investigated the dependence of the morphology 
and size of the siRNA nanoparticles formed upon different exposure 
times to ultrasonic waves by high resolution scanning electron 
microscopy (HRSEM) and scanning transmission electron microscopy 
(STEM) (Figure 1a). A reduction in size was observed for nanoparticles 
formed under longer exposure time of 3 min with particle size of 65 nm 
(Figure 1b), while for shorter sonication time (1 min) the average size 
of siRNA nanoparticles was about 80 nm (Figure 1a). Interestingly, the 
generation of particles under the longer exposure time, for more than 
5 min, led to smaller particle size of about 15 nm with reduction in 
efficiency of nanoparticle formation for 50%. The exposure of siRNA 
molecules to ultrasound for longer than 15 min led to complete RNA 
degradation. We propose that this effect is due to the fact that cavitation 
bubbles produced in aqueous media collapse in an implosive manner 
and generate locally extreme physico-chemical conditions that promote 
nanoparticles formation or, in its excess, lead to particles dissociation 
and RNA degradation. To this effect, we probed the stability of RNA 
nanoparticles under ultrasonic waves by exposing nanoparticles to 
ultrasound and monitored the particles dissociation. After 10 min 
exposure, there were no particles detected in the solution with complete 
degradation of free RNA molecules was achieved after 15 min exposure 
time (See Supporting Information). It is worth to mention that exposure 
of RNA molecules to ultrasonic frequencies higher than 40% amplitude 
(See methods section) lead to complete RNA degradation.
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Figure 1: (a) HRSEM images of siRNA nanoparticles formed within 1 min 
of sonication time and (b) within 3 min sonication time. The corresponding 
STEM images of siRNA nanoparticles are shown in the right corner of each 
image. Scale bars=100 nm; (c) diagram for the mechanism of sonochemical 
siRNA nanoparticles formation resolved from MD simulations of siRNA 
molecules in water; (d) size distribution (obtained from DLS analysis) 
histogram for free siRNA molecules, siRNA nanoparticles created within 1, 
3 and 5 min sonication time. The exact are shown in Supportin Information.
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In order to obtain the more detailed understanding of the 
mechanism of siRNA nanoparticles formation we followed the RNA 
molecular changes by means of molecular dynamic simulations (MD). 
The MD results are presented in Figure 1c. The simulations show that 
the subsequent application of ultrasonic energy leads to reorganization 
of RNA structure and further formation of dense siRNA nanoparticle.
The stability of the sonochemically formed siRNA nanoparticles 
was probed in the presence of degrading RNase enzyme, for wide 
range of pH and temperatures varying from 4°C to 37°C (See 
Methods). The effect of pH, temperature and enzymatic changes 
in the siRNA nanoparticles stability in solution was studied by 
HRSEM microscopy following the nanoparticles dissociation. The 
nanoparticulate content was measured in the lower aqueous phase 
after nanoparticles separation (See methods). Under bulk conditions, 
siRNA nanoparticles remained stable for approximately 24 hours 
followed by nanoparticles dissociation process. By contrast, we found 
that at 4°C the dense nanoparticles retained its stability for 1 month 
and for 70 min at 37°C, suggesting that the dense siRNA packing in 
the nanoparticles structure protects the molecules effectively against 
degradation under ambient conditions. It is worth to mention that free 
siRNA molecules are stable under ambient conditions for 1.5-2 hours 
and up to 24 hours at 4°C and unstable at 37°C. siRNA nanoparticles 
were found to be stable at pH values varying from 4.5 to 9 for 24 h 
(average value ± 4 h). The further decrease or increases in pH of the 
dispersion lead to particles dissociation followed by RNA degradation. 
The sonochemically formed siRNA nanoparticles were found to be 
stable in the presence of degradative RNase enzymes for at least 3 hours. 
The results of siRNA stability studies are presented in Figure 2a. siRNA 
nanoparticles were found to be negatively charged with an electrical 
charge of -19.9 mV. The electrical charge of native RNA molecules was 
found to be -31.8 mV (Figure 2b). Due to the fact that sonochemically 
formed nanoparticles are negatively charged, they have a tendency to 
repel each other. As a result they stay dispersed and colloidal in water. 
The zeta potential measurements were performed on a dynamic light 
scattering apparatus. The negative charge indicates that the negative 
phosphate groups are directed from the nanoparticles interface towards 
the solution. In order to understand the origin of difference in electrical 
charge between the native siRNA molecules and siRNA nanoparticles, 
we quantified the counter ions fraction by inductively coupled plasma 
(ICP). Due to the fact that all the experiments were performed in DDW, 
the only source of the detected counter ions is RNA storage buffer (See 
Methods section). Interestingly, the fraction of counter ions of Na+, 
Mg2+ and Ca2+ in siRNA nanoparticles was found to be higher than for 
native RNA molecules (Figure 2b). This formulation and composition 
of RNA nanoparticle structure allows neutralization of the negatively 
charged phosphate groups localized at the outer surface of the siRNA 
nanoparticles.
The transfer of siRNA into non-viral cells is a complicated 
procedure because it involves the use of different mediators. In the 
current study the nanoparticles were successfully introduced into the 
aorta bovine endothelial cells without use of any additional transfection 
agents. The maximal particle size that are able to penetrate the cells, can 
reach 400–500 nm, while the relative size of the cells is about 20 μm. 
Thus the nanoscale size of siRNA particles have an advantage over the 
conventional micronscale delivery systems. Fluorescently labeled Cy3-
siRNA nanoparticles spontaneously penetrated into the cells. Figure 
3a depicts the entrance of the siRNA nanoparticles into the bovine 
endothelial cell. A control experiment shows that no fluorescent signal 
was detected when the Cy3-siRNA molecules were exposed to cells 
(See methods) due to the low efficiency of the internalization of RNA 
in the monomeric form and as a consequence of the dilution of any 
Cy3-siRNA inside the cell to the entire cytoplasmic volume. Next, we 
explored the silencing activity of siRNA nanoparticles. The ability of 
lucefirase siRNA and anti-GFP siRNA nanoparticles to silence the genes 
was probed on endothelial bovine and 293T/GFP-Puro cell cultures 
(Figure 3b and c). The observation confirms the better silencing by 
siRNA nanoparticles compared to siRNA molecules in its native state 
(as a negative control), since the repression of desired genes (firefly for 
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Figure 2: (a) Stability studies for siRNA nanoparticles and free siRNA 
molecules as a function of temperature (4°C, 25°C and 37°C), pH changes 
(from 4,5 to 9) and presence of RNases in solution. HRSEM images of siRNA 
nanoparticles before and after dissociation are shown at the top part of the 
graph. Scale bars=100 nm; (b) chart summarizing average zeta-potential (in 
mV) and counter ions concentrations (mg/L) for nanoparticulate siRNA and 
free siRNA molecules.
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Figure 3: (a) Introduction of Cy3RNA nanoparticles into the aorta bovine 
endothelial cells: (i) fluorescent image of endothelial cell loaded with Cy3RNA 
nanoparticles, (ii) DIC image of i; (iii) fluorescent image of endothelial cell 
incubated with free siRNA; (iv) DIC image of iii. (b) fluorescent images of 
the GFP gene silencing in 293T/GFP-Puro cells using anti-GFPsiRNA 
nanoparticles: (i) untreated cells, (ii) cells treated with nanoparticles prepared 
via 1 min sonication time, (iii) cells treated with nanoparticles prepared via 
3 min sonication time, (iv) cells incubated with free anti-GFPsiRNA. (c) 
silencing results of GFP and firefly genes (left green bars indicate renila 
silencing efficiency). The gene silencing activity was probed on the cells 
treated with: (i) free siRNA molecules, (ii) siRNA nanoparticles created via 1 
min sonication and (iii) siRNA nanoparticles created via 3 min sonication. (d) 
cell viability test for free siRNA molecules, siRNA nanoparticles created via 
1 min sonication and siRNA nanoparticles created via 3 min sonication for 
bovine aorta endothelial cell lines.
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endothelial cells and GFP for 293T/GFP-Puro cells) was achieved by 
treating cell lines with siRNA nanoparticles. Figure 3b and c depicts the 
gene silencing results for firefly gene silencing in endothelial cells and 
GFP gene silencing in 293T/GFP-Puro. Maximal silencing effect (for 
GFP and Luciferase silencing via nanoparticles created within 3 min 
sonication time ≈80% ± 3.4 silencing), comparable with Lipofectamine 
and polyethyleneimine (≥ 80% av. silencing efficiency reported by 
Maurisse et al.) was achieved. However, for nanoparticles created 
within 1 min sonication time, the lower silencing effect of about 60% 
was achieved. 
Finally we tested whether or not the observed silencing effect 
is resulted from siRNA nanoparticles toxicity. In order to examine 
the biocompatibility of the siRNA nanoparticles for gene silencing 
applications, their toxicity was examined using MTS toxicity assay (See 
Methods). The nanoparticlulate siRNA was found to be non-toxic for 
the cells as shown in Figure 3d.
Conclusions
In conclusion, we described a general approach for conversion 
of siRNA molecules into the dense siRNA nanoparticles using 
environmentally friendly ultrasonic method. Our system does not 
contain protein or peptides, and thus the use of such protein-free 
nanoparticles to avoid immune response would allow for long-
term administration in the treatment of chronic diseases. SiRNA 
nanoparticulate structures produced by ultrasonic method, in addition 
to gene silencing abilities, have been shown to be resistant to a variety of 
environmental stresses including a wide range of pH and temperature 
levels and presence of enzymes. Understanding and controlling the 
siRNA behavior opens the variety of possible applications in the field of 
nanomedicine and bionanotechnology.
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